| Shamica N Williams, CNA | |
|
503 Jean St Apt 3, Daytona Beach, FL 32114-4673 | |
| (386) 675-3365 | |
| Not Available |
| Full Name | Shamica N Williams |
|---|---|
| Gender | Female |
| Speciality | Clinical Nurse Specialist - Home Health |
| Location | 503 Jean St Apt 3, Daytona Beach, Florida |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568042646 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SH0200X | Clinical Nurse Specialist - Home Health | CNA267173 (Florida) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Shamica N Williams, CNA 503 Jean St Apt 3, Daytona Beach, FL 32114-4673 Ph: (386) 675-3365 | Shamica N Williams, CNA 503 Jean St Apt 3, Daytona Beach, FL 32114-4673 Ph: (386) 675-3365 |
News Archive
Microcapsules with a broad spectrum of applications in biomedicine, catalysis, and technology can be produced by using plant-derived, phenolic tannic acid and a variety of metals. The capsules are formed by a simple self-assembly process, and their properties can be controlled through the choice of metal, as demonstrated by a team of Australian and German researchers in the journal Angewandte Chemie.
Pathway Medical Technologies, Inc., an innovator of endovascular treatments for peripheral vascular disease (PVD), today announced that the U.S. Food & Drug Administration (FDA) has granted the company 510(k) clearance to market JETSTREAM G3™ SF (Small Fixed), the newest version of its peripheral revascularization catheter for the treatment of PVD.
The researchers assessed glucose production to check for insulin resistance in the mice that gorged and then fasted and found that they had indeed developed insulin resistance in their livers, which is an indicator of prediabetes...
Bionic Vision Australia (BVA), a consortium of researchers working together to develop bionic eye devices to restore a sense of vision to people with profound vision loss, today announced the successful completion of the first clinical trial of its prototype 24-channel percutaneous implant in patients with profound vision loss from the eye disease retinitis pigmentosa (RP).
› Verified 4 days ago
Markecia English, CNA Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 315 Wilder Blvd Apt 205, Daytona Beach, FL 32114 Phone: 386-344-8562 | |
Catherine Vesely, ARNP Clinical Nurse Specialist Medicare: Medicare Enrolled Practice Location: 303 N Clyde Morris Blvd, Daytona Beach, FL 32114 Phone: 386-425-2360 Fax: 386-226-4577 |